WO2019024017A1 - 一种用于增强免疫的中药胶囊 - Google Patents

一种用于增强免疫的中药胶囊 Download PDF

Info

Publication number
WO2019024017A1
WO2019024017A1 PCT/CN2017/095687 CN2017095687W WO2019024017A1 WO 2019024017 A1 WO2019024017 A1 WO 2019024017A1 CN 2017095687 W CN2017095687 W CN 2017095687W WO 2019024017 A1 WO2019024017 A1 WO 2019024017A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
ganoderma lucidum
chinese medicine
enhancing immunity
medicine capsule
Prior art date
Application number
PCT/CN2017/095687
Other languages
English (en)
French (fr)
Inventor
陈惠�
郑惠华
陈莹莹
陆汉萍
陈锷
吴伟杰
Original Assignee
江苏安惠生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江苏安惠生物科技有限公司 filed Critical 江苏安惠生物科技有限公司
Priority to PCT/CN2017/095687 priority Critical patent/WO2019024017A1/zh
Publication of WO2019024017A1 publication Critical patent/WO2019024017A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Definitions

  • the present invention relates to a health care product.
  • An object of the present invention is to provide a ganoderma lucidum composite capsule which is rich in nutrients and enhances immunity.
  • An enhanced immunity Ganoderma lucidum composite capsule characterized by: consisting of the following weight percentage components [0005] Ganoderma lucidum extract 35%
  • the invention is rich in nutrients, has various health and nutrition components, is convenient to manufacture, and enhances immunity.
  • the ganoderma lucidum extract is obtained by the following method: drying and pulverizing the ganoderma lucidum, passing through a 10-mesh sieve, extracting the coarse granules twice with water, and first extracting 2 small waters equivalent to 10 times the weight of the coarse granules. ⁇ , the second time with the equivalent of 8 times the weight of the coarse particles of water extraction 2 small sputum, the second extract is combined and concentrated to a specific gravity of 1.30, then the extract at 80 ° C, 0.08Mpa conditions Dry under reduced pressure, and smash through 80 ⁇ 100 mesh sieve to obtain dry extract powder
  • the Hericium erinaceus extract is obtained by the following method: Drying and pulverizing the Hericium erinaceus, passing through a 10-mesh sieve, extracting the coarse granules twice with water, and using water equivalent to 10 times the weight of the coarse granules for the first time. 2 times of leaching, 2 times of leaching with water equivalent to 8 times the weight of coarse particles, and the second extract is combined and concentrated to a specific gravity of 1.30, and then the extract is at 80 ° C, The mixture was dried under reduced pressure at 0.08 MPa, and pulverized through a sieve of 80 to 100 mesh to obtain a dry extract powder, that is, an extract of Hericium erinaceus.
  • the Schisandra extract is obtained by the following method: drying and pulverizing the Schisandra, passing through a 10-mesh sieve, and extracting the coarse-grained water twice, and firstly extracting 2 times with water equivalent to 10 times the weight of the coarse grain. ⁇ , the second time with the equivalent of 8 times the weight of the coarse particles of water extraction 2 small sputum, the second extract is combined and concentrated to a specific gravity of 1.30, then the extract at 80 ° C, 0.08Mpa conditions It is dried under reduced pressure and pulverized through a sieve of 80 to 100 mesh to obtain a dry extract powder, that is, a Schisandra extract.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

一种用于增强免疫的中药胶囊，由如下重量百分比的组分组成：灵芝提取物（35%）、蝙蝠蛾拟青霉菌粉（25%）、猴头菇提取物（20%）、五味子提取物（20%）。

Description

一种用于增强免疫的中药胶囊
技术领域
[0001] 本发明涉及一种保健品。
背景技术
[0002] 现有的保健品众多， 但在营养成分、 增强免疫力的等方面存在各种缺陷。
技术问题
[0003] 本发明的目的在于提供一种营养丰富增强免疫力的灵芝复合胶囊。
问题的解决方案
技术解决方案
[0004] 一种增强免疫力的灵芝复合胶囊， 其特征是： 由下列重量百分比的成分组成 [0005] 灵芝提取物 35%
[0006] 蝙蝠蛾拟青霉菌粉 25%
[0007] 猴头菇提取物 20%
[0008] 五味子提取物 20%。
发明的有益效果
有益效果
[0009] 本发明营养丰富， 具有多种保健营养成分， 制作方便， 增强免疫力。
实施该发明的最佳实施例
本发明的最佳实施方式
[0010] 一种增强免疫力的灵芝复合胶囊， 由下列重量百分比的成分混合、 装胶囊制
[0011] 灵芝提取物 35%
[0012] 蝙蝠蛾拟青霉菌粉 25%
[0013] 猴头菇提取物 20%
[0014] 五味子提取物 20%。 [0015] 所述灵芝提取物是通过下列方法制得： 将灵芝干燥、 粉碎， 过 10目筛， 粗粒加 水提取两次， 第一次用相当于粗粒重量 10倍的水浸提 2小吋， 第二次用相当于粗 粒重量 8倍的水浸提 2小吋， 二次浸提液合并后浓缩至比重为 1.30的浸膏， 然后对 浸膏在 80°C、 0.08Mpa的条件下减压干燥， 并粉碎过 80~100目筛， 得到干浸膏粉
， 即灵芝提取物。
[0016] 所述猴头菇提取物是通过下列方法制得： 将猴头菇干燥、 粉碎， 过 10目筛， 粗 粒加水提取两次， 第一次用相当于粗粒重量 10倍的水浸提 2小吋， 第二次用相当 于粗粒重量 8倍的水浸提 2小吋， 二次浸提液合并后浓缩至比重为 1.30的浸膏， 然 后对浸膏在 80°C、 0.08Mpa的条件下减压干燥， 并粉碎过 80~100目筛， 得到干浸 膏粉， 即猴头菇提取物。
[0017] 所述五味子提取物是通过下列方法制得： 将五味子干燥、 粉碎， 过 10目筛， 粗 粒加水提取两次， 第一次用相当于粗粒重量 10倍的水浸提 2小吋， 第二次用相当 于粗粒重量 8倍的水浸提 2小吋， 二次浸提液合并后浓缩至比重为 1.30的浸膏， 然 后对浸膏在 80°C、 0.08Mpa的条件下减压干燥， 并粉碎过 80~100目筛， 得到干浸 膏粉， 即五味子提取物。

Claims

权利要求书
[权利要求 1] 一种增强免疫力的灵芝复合胶囊， 其特征是： 由下列重量百分比的成 分组成：
灵芝提取物 35%
蝙蝠蛾拟青霉菌粉 25%
猴头菇提取物 20%
五味子提取物 20%。
PCT/CN2017/095687 2017-08-02 2017-08-02 一种用于增强免疫的中药胶囊 WO2019024017A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/095687 WO2019024017A1 (zh) 2017-08-02 2017-08-02 一种用于增强免疫的中药胶囊

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/095687 WO2019024017A1 (zh) 2017-08-02 2017-08-02 一种用于增强免疫的中药胶囊

Publications (1)

Publication Number Publication Date
WO2019024017A1 true WO2019024017A1 (zh) 2019-02-07

Family

ID=65232241

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/095687 WO2019024017A1 (zh) 2017-08-02 2017-08-02 一种用于增强免疫的中药胶囊

Country Status (1)

Country Link
WO (1) WO2019024017A1 (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1969955A (zh) * 2006-11-29 2007-05-30 江苏安惠生物科技有限公司 食用菌保健胶囊及生产方法和用途
CN101292742A (zh) * 2008-06-07 2008-10-29 江中药业股份有限公司 一种增强人体免疫功能的保健食品及其制备工艺

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1969955A (zh) * 2006-11-29 2007-05-30 江苏安惠生物科技有限公司 食用菌保健胶囊及生产方法和用途
CN101292742A (zh) * 2008-06-07 2008-10-29 江中药业股份有限公司 一种增强人体免疫功能的保健食品及其制备工艺

Similar Documents

Publication Publication Date Title
CN101664422B (zh) 灵芝挥发油、灵芝酸和灵芝多糖超临界流体提取工艺
CN104305202A (zh) 一种超微辣木粉压缩含片及其制备方法
CN102302684A (zh) 三七活血通片
CN103211219B (zh) 一种缓解体力疲劳的保健食品及其制备方法
WO2017197787A1 (zh) 一种枸杞补血酒
CN108991332A (zh) 一种灰树花、蛹虫草食用菌固体饮料
CN105816693B (zh) 一种石斛超微粉制备工艺
CN105394511B (zh) 一种具有增强免疫力作用的含玛咖速溶冲剂及其制备方法
CN106538797A (zh) 一种玫瑰咖啡及其制备方法
CN101274028B (zh) 肝脏保健组合物及其制备方法
WO2019024017A1 (zh) 一种用于增强免疫的中药胶囊
CN107223982A (zh) 一种快速提取动植物全营养精华素的方法
CN101589795A (zh) 灵芝虫草酱油及制备方法
CN103652155A (zh) 一种速溶分子保健茶
WO2019024015A1 (zh) 增强免疫力的健胃保健胶囊
WO2019024018A1 (zh) 增强免疫力的强身健力胶囊
WO2019024019A1 (zh) 增强免疫力的养肺胶囊
WO2019024012A1 (zh) 增强免疫力的改善睡眠胶囊
WO2019024013A1 (zh) 增强免疫力的护肝保健胶囊
WO2019024014A1 (zh) 增强免疫力的缓解疲劳保健胶囊
CN104450378A (zh) 一种醋栗黑枣果酒
CN106822191A (zh) 一种灵芝冬虫夏草提取物的组合物及其纯片制备方法
WO2019024011A1 (zh) 增强免疫力的复合食用菌茶包
WO2013155713A1 (zh) 灵芝复合胶囊
CN110115376A (zh) 一种雨生红球藻蛹虫草片及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17920612

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17920612

Country of ref document: EP

Kind code of ref document: A1